
Hidradenitis Suppurativa
By: Gregor Jemec (Editor), Jean Revuz (Editor), James J. Leyden (Editor)
Hardcover | 5 October 2006
At a Glance
224 Pages
25.4 x 18.42 x 1.91
Hardcover
$359.00
or 4 interest-free payments of $89.75 with
 orÂShips in 7 to 10 business days
Industry Reviews
From the reviews:
"The book gives a good historical overview on HS emphasizing on the many confusing names the disease has been given since its first description more than a hundred years ago and the century long discussion of the involvement of apocrine glands in the pathology of the disease. ... In conclusion, this book is well structured, easy to read and are a great source of information ... . recommendable for all physicians with more than a superficial interest in HS." (Elisabeth Eiling, Archives of Dermatological research, Vol. 299, 2007)
| Hidradenitis Suppurativa Introduction | |
| References | p. 3 |
| Verneuil and Verneuil's Disease: an Historical Overview | |
| Biographical Landmarks of a Surgeon-Venereologist | p. 4 |
| L'Hidradenite Phlegmoneuse (Verneuil's Disease), Primary Observations | p. 5 |
| Further Observations and Discussions in Europe and Overseas | p. 6 |
| Hidrosadenitis and Acne Conglobata: Controversial Views | p. 8 |
| Acne Inversa, the Last Metamorphosis of Verneuil's Disease? | p. 9 |
| References | p. 9 |
| Clinical Presentation | |
| Introduction | p. 11 |
| Individual Lesions | p. 12 |
| Primary (Early) Lesions | p. 12 |
| Secondary Lesions | p. 13 |
| Tertiary Lesions | p. 14 |
| Comedones | p. 15 |
| Other Lesions | p. 15 |
| Topography | p. 16 |
| Involved Areas | p. 16 |
| Two Main Zones | p. 16 |
| The Two Less Frequently Involved Zones | p. 17 |
| Atypical Localizations - Other Zones May Be Involved | p. 17 |
| Distribution of Lesions | p. 18 |
| Evolution of the Disease and its Severity | p. 19 |
| Age at Onset and Resolution | p. 19 |
| Clinical Course | p. 19 |
| Intermittent/Benign Course of the Disease | p. 20 |
| Intermediate Course of the Disease | p. 20 |
| Continuous Disease: Moderate, Severe | p. 20 |
| Severity Indexes | p. 21 |
| Hurley's Clinical Staging [2] | p. 21 |
| Sartorius [9] | p. 21 |
| Diagnosis | p. 22 |
| Diagnostic Criteria | p. 22 |
| Delay in Diagnosis | p. 22 |
| Differential Diagnoses | p. 23 |
| References | p. 23 |
| Pathology of Hidradenitis Suppurativa | |
| Introduction | p. 25 |
| Glandular Elements of the Skin | p. 26 |
| Sebaceous Glands and the Pilosebaceous Unit | p. 26 |
| Apocrine Glands | p. 27 |
| Eccrine Glands | p. 27 |
| Apoeccrine Glands | p. 27 |
| Histological Appearance of HS | p. 27 |
| Early Lesions | p. 27 |
| Established Hidradenitis Suppurativa | p. 28 |
| Immunohistochemistry of Hidradenitis Suppurativa | p. 30 |
| Cytokeratin Expression in HS | p. 30 |
| Comparison with Other Disorders | p. 31 |
| Fox-Fordyce Disease | p. 31 |
| Acne | p. 31 |
| Follicular Occlusion Triad | p. 31 |
| Pilonidal Sinus | p. 31 |
| Crohn's Disease | p. 32 |
| Conclusions | p. 32 |
| Acknowledgements | p. 33 |
| References | p. 33 |
| Imaging | |
| Introduction | p. 34 |
| Ultrasound | p. 34 |
| Magnetic Resonance Imaging (MRI) | p. 36 |
| X-Ray Examination | p. 36 |
| Discussion | p. 36 |
| References | p. 37 |
| Associated Diseases: Causality or Complications? | |
| Introduction | p. 38 |
| Cutaneous Diseases (Excluding Squamous Cell Carcinomas) | p. 39 |
| Follicular Occlusion Diseases | p. 39 |
| Acne Conglobata | p. 40 |
| Dissecting Folliculitis of the Scalp | p. 40 |
| Pilonidal Sinus | p. 41 |
| Pigmentation Disorders of the Skin Folds: Dowling-Degos and Kitamura's Diseases | p. 41 |
| Rheumatological Disorders | p. 42 |
| Clinical Picture | p. 42 |
| Radiographic Features | p. 42 |
| Treatment | p. 42 |
| Mechanisms | p. 43 |
| Associated Cancers | p. 43 |
| Non-Skin Cancers | p. 43 |
| Squamous Cell Carcinoma | p. 44 |
| Incidence and Prevalence | p. 44 |
| Clinical Picture | p. 44 |
| Differential Diagnosis | p. 45 |
| Treatment | p. 45 |
| Prognosis | p. 45 |
| Other Co-Occurrences | p. 45 |
| Conclusion | p. 46 |
| References | p. 46 |
| Hidradenitis Suppurativa and Crohn's Disease | |
| Definition and Course of Crohn's Disease | p. 50 |
| Pathophysiology | p. 50 |
| Genetic Factors | p. 51 |
| Enteric Microflora | p. 51 |
| Immune-Mediated Tissue Injury | p. 51 |
| Pathology | p. 51 |
| Clinical Aspects | p. 52 |
| Disease Location | p. 52 |
| Clinical Presentation | p. 52 |
| Therapeutic Aspects and Prognosis | p. 52 |
| Cutaneous Crohn's Disease | p. 52 |
| Clinical Presentation of Cutaneous Lesions | p. 53 |
| Therapeutic Aspects and Prognosis | p. 53 |
| Crohn's Disease and Hidradenitis Suppurativa | p. 53 |
| Differential Diagnosis | p. 53 |
| Co-Existence of HS and CD | p. 55 |
| Treatment of Perianal Co-existent CD and HS | p. 55 |
| References | p. 55 |
| Epidemiology | |
| Introduction | p. 58 |
| Descriptive Epidemiology | p. 58 |
| Analytic Epidemiology | p. 60 |
| Clinical Epidemiology: Natural History and Prognosis | p. 62 |
| Perspectives | p. 63 |
| References | p. 64 |
| Nosology and Classification | |
| Introduction | p. 65 |
| Morphology | p. 66 |
| Anatomy | p. 66 |
| Clinical Features | p. 66 |
| Etiology; Pathogenesis | p. 67 |
| Infection | p. 67 |
| Inflammation | p. 68 |
| Hormones | p. 68 |
| Treatments | p. 68 |
| Conclusion | p. 69 |
| Genetics of Hidradenitis Suppurativa | |
| Clinical Genetics of Hidradenitis Suppurativa | p. 70 |
| Genodermatoses | p. 74 |
| Methods for Identifying Disease Genes | p. 74 |
| Genetic Markers | p. 75 |
| Positional Cloning of Dominantly Inherited Disease Genes | p. 75 |
| Genome-Wide Linkage Analysis in Familial HS | p. 77 |
| Linkage of Hidradenitis Suppurativa to 6q25.2 | p. 78 |
| Identification of a Second HS Locus to Chromosome 19 | p. 79 |
| Candidate Genes Analysed in Linked HS Kindreds | p. 79 |
| Oestrogen receptor-[alpha] and HS | p. 79 |
| ZNF91 and HS | p. 79 |
| TIZ Association with HS | p. 80 |
| Potential Contribution of the VIP Gene to HS | p. 80 |
| Additional Candidate Gene-Protein Systems in HS | p. 81 |
| Interleukin 1-[alpha] | p. 81 |
| TNF Signalling and HS | p. 81 |
| Discussion | p. 81 |
| Conclusions | p. 82 |
| References | p. 83 |
| Bacteriology of Hidradenitis Suppurativa | |
| Normal Microflora of the Skin | p. 86 |
| Bacteria Found in HS Lesions | p. 87 |
| General Factors About Bacterial Involvement in HS Pathogenicity | p. 90 |
| The Role of Antibiotics in the Treatment of HS | p. 91 |
| Possible Consequences for Bacterial Ecology due to Antibiotic Treatment in HS | p. 92 |
| References | p. 92 |
| Endocrinology | |
| Introduction | p. 95 |
| Hyperandrogenism and the Skin | p. 95 |
| Androgenization | p. 95 |
| Androgen Metabolism | p. 96 |
| Causes of Hyperandrogenism | p. 96 |
| Lack of Association between HS and Endocrinopathies | p. 97 |
| HS and Biological Hyperandrogenism | p. 97 |
| End-Organ Androgen Sensitivity? | p. 98 |
| References | p. 98 |
| Immunity | |
| Introduction | p. 100 |
| Ancient and Modern: Innate and Acquired Immunity | p. 101 |
| TLR/IL-1R Superfamily and their Signaling Pathways in the Skin | p. 102 |
| Members of the TLR Family Expressed by Keratinocytes | p. 102 |
| IL-1 Receptors in the Skin | p. 104 |
| Signaling Pathways via TLR/IL-1R | p. 104 |
| MyD88-Dependent Signaling Pathway | p. 104 |
| MyD88-Independent Signaling Pathway | p. 105 |
| Keratinocyte-Derived Effector Molecules in the Innate Immune System of the Skin | p. 105 |
| Antimicrobial Peptides | p. 105 |
| [Beta]-Defensins | p. 106 |
| Cathelicidins | p. 106 |
| RNase7 | p. 107 |
| Antileukoprotease (ALP) | p. 107 |
| Pro-Inflammatory Chemokines | p. 107 |
| Pro-Inflammatory Cytokines | p. 108 |
| TLR Recognition and the Commensal Microbiota of the Skin | p. 109 |
| Skin Infections and Innate Immune Responses of the Epidermis | p. 110 |
| Hidradenitis Suppurativa and the Skin Immune System | p. 110 |
| Conclusions | p. 112 |
| References | p. 112 |
| Quality of Life in Hidradenitis Suppurativa | |
| Introduction | p. 116 |
| Concept and Measure of Quality of Life | p. 116 |
| Why Try to Measure Quality of Life? | p. 116 |
| Reporting the Viewpoint of Patients: Methods of Measurement of Quality of Life | p. 117 |
| Reporting the Viewpoint of Physicians: Uniform Outcome Variables | p. 117 |
| Practical Approach Reconciling the Viewpoints of Patients and Physicians | p. 117 |
| Impact of HS upon Quality of Life | p. 117 |
| Altered Self-Reported Health: Qualitative Approach | p. 117 |
| Measure of Quality of Life: Quantitative Approach | p. 118 |
| Impaired Quality of Life: What Conclusion? | p. 118 |
| Conclusion for Patients | p. 118 |
| Conclusion for Physicians | p. 119 |
| References | p. 119 |
| Antibiotic Therapy | |
| Introduction | p. 120 |
| Clinical Experience | p. 121 |
| Therapy | p. 121 |
| References | p. 123 |
| Antiandrogens | |
| Introduction | p. 124 |
| Antiandrogens and Antiandrogen Therapies | p. 124 |
| Cyproterone Acetate | p. 125 |
| Spironolactone | p. 125 |
| Finasteride | p. 125 |
| Antiandrogenic Progestins | p. 125 |
| Oral Contraceptives | p. 125 |
| Antiandrogens in HS | p. 126 |
| Cyproterone Acetate | p. 126 |
| Spironolactone | p. 126 |
| Finasteride | p. 126 |
| References | p. 127 |
| Oral Retinoids for Hydradenitis Suppurativa | |
| Introduction | p. 128 |
| Isotretinoin | p. 128 |
| Mechanism of Action [1, 2] | p. 128 |
| Clinical Experience | p. 129 |
| Isotretinoin Monotherapy for HS | p. 129 |
| Isotretinoin Therapy in Patients with Acne and Coexistent HS | p. 129 |
| Isotretinoin in the Pre- and Postoperative Phase | p. 131 |
| Isotretinoin in Combination Treatment of HS | p. 131 |
| Side-Effects | p. 131 |
| Etretinate and Acitretin | p. 132 |
| Mechanism of Action | p. 132 |
| Clinical Experience: Etretinate and Acitretin for HS | p. 132 |
| Side-Effects | p. 134 |
| References | p. 134 |
| Immunosuppressive Therapy in Hidradenitis Suppurativa | |
| Introduction | p. 136 |
| What Can We Achieve With Therapy? | p. 137 |
| Immunosuppressive Therapies | p. 137 |
| Prednisolone and Other Corticosteroids | p. 138 |
| Ciclosporin | p. 138 |
| Dapsone | p. 138 |
| Methotrexate | p. 138 |
| Hidradenitis Suppurativa as a Side-Effect of Immuno-suppressive Drugs | p. 139 |
| Practical Use of Immuno-suppressive Therapy | p. 139 |
| References | p. 140 |
| Zinc and Other Experimental Medical Treatments | |
| Introduction | p. 141 |
| Zinc Salts | p. 141 |
| Mechanisms of Action: Modulation of the Proliferation and Differentiation of Keratino-cytes and Cell Apoptosis | p. 141 |
| Anti-Inflammatory Activity | p. 142 |
| Activity Against 5[alpha]-Reductase | p. 142 |
| Healing | p. 142 |
| Zinc Salts in Verneuil's Disease | p. 142 |
| Other Experimental Drugs | p. 143 |
| References | p. 144 |
| Biologics For Hidradenitis Suppurativa (Verneuil's Disease in the Era of Biologics) | |
| Introduction | p. 145 |
| Background | p. 145 |
| Crohn's Disease and Hidradenitis Suppurativa Co-Occurrence: A Rationale for Anti-TNF Therapy | p. 147 |
| Anti-TNF Drugs in HS | p. 147 |
| Future Prospects | p. 148 |
| References | p. 149 |
| Topical Treatment | |
| Introduction | p. 150 |
| Antibiotics | p. 151 |
| Topical Clindamycin | p. 152 |
| Keratolytics | p. 152 |
| Resorcinol as a Keratolytic Agent in Hidradenitis Suppurativa | p. 152 |
| Indications | p. 154 |
| Mechanism of Action | p. 154 |
| Side-Effects of Resorcinol | p. 155 |
| Treatment Schedule with Resorcinol Creams | p. 156 |
| Clinical Experience | p. 156 |
| Topical Anti-Inflammatory Therapy | p. 157 |
| Azelaic Acid | p. 157 |
| Fusidic Acid | p. 157 |
| Intralesional Therapy | p. 157 |
| The Use of Local Therapy | p. 158 |
| Publication Bias | p. 158 |
| References | p. 159 |
| Surgery | |
| Introduction | p. 161 |
| Methods of Closure | p. 164 |
| Anatomical Regions Involved | p. 165 |
| Axillary HS | p. 165 |
| Inguinal Disease | p. 165 |
| Gluteal-Perianal-Perineal Disease | p. 165 |
| Excision Margins | p. 166 |
| Complications | p. 166 |
| Recurrent Disease After Surgery | p. 167 |
| Carbon Dioxide Laser Surgery in HS | p. 167 |
| Anesthesia | p. 168 |
| Postoperative Wound Care | p. 168 |
| Practical Hints and Comments | p. 168 |
| The Carbon Dioxide Laser Technique | p. 168 |
| The Use of Scanners | p. 169 |
| How Radical Should the Therapy Be? | p. 170 |
| Concluding Remarks | p. 171 |
| References | p. 171 |
| Radiation Therapy | |
| Introduction | p. 174 |
| Treatment Regimens | p. 175 |
| Case Series Reports | p. 175 |
| Conclusion | p. 175 |
| References | p. 175 |
| Experimental Physical Therapies | |
| Introduction | p. 177 |
| Photodynamic Therapy | p. 177 |
| Depilation | p. 179 |
| Cryosurgery | p. 179 |
| Discussion | p. 180 |
| Practical Guidelines for Testing New Physical Therapies | p. 180 |
| References | p. 181 |
| Treatment | |
| Introduction | p. 183 |
| Staging the Disease | p. 183 |
| Treatment of Hidradenitis Suppurativa Hurley Stage I | p. 184 |
| Treatment of Hidradenitis Suppurativa Hurley Stage II | p. 184 |
| Treatment of Hidradenitis Suppurativa Hurley Stage III | p. 185 |
| Hidradenitis Suppurativa with Cysts | p. 185 |
| Experimental Therapies | p. 186 |
| General Requirements for Treatment | p. 186 |
| Hidradenitis Suppurativa - Patients' Frequently Asked Questions | |
| General Questions | p. 187 |
| Heredity | p. 188 |
| Pregnancy | p. 188 |
| Treatment | p. 189 |
| Practical Questions | p. 189 |
| Hints For Daily Life | p. 190 |
| Relations To Other Factors | p. 190 |
| Psychological Aspects | p. 191 |
| Children and Adolescents | p. 192 |
| Social Security | p. 192 |
| An Uncommon Valor | |
| Kevin | p. 194 |
| Deborah | p. 195 |
| Elizabeth | p. 195 |
| Melony | p. 195 |
| Kerrie | p. 196 |
| John | p. 197 |
| Caroline | p. 197 |
| Arnold | p. 197 |
| Mabel | p. 198 |
| Nassim | p. 199 |
| Mira | p. 199 |
| Mindy | p. 200 |
| Subject Index | p. 201 |
| Table of Contents provided by Ingram. All Rights Reserved. |
ISBN: 9783540331001
ISBN-10: 354033100X
Published: 5th October 2006
Format: Hardcover
Language: English
Number of Pages: 224
Audience: Professional and Scholarly
Publisher: Springer Nature B.V.
Country of Publication: DE
Dimensions (cm): 25.4 x 18.42 x 1.91
Weight (kg): 0.61
Shipping
| Standard Shipping | Express Shipping | |
|---|---|---|
| Metro postcodes: | $9.99 | $14.95 |
| Regional postcodes: | $9.99 | $14.95 |
| Rural postcodes: | $9.99 | $14.95 |
Orders over $79.00 qualify for free shipping.
How to return your order
At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.
Additional postage charges may be applicable.
Defective items
If there is a problem with any of the items received for your order then the Booktopia Customer Care team is ready to assist you.
For more info please visit our Help Centre.
You Can Find This Book In
This product is categorised by
- Non-FictionFamily & HealthPopular Medicine & HealthWomen's Health
- Non-FictionMedicineClinical & Internal MedicineDermatology
- Non-FictionMedicineClinical & Internal MedicineGynaecology & Obstetrics
- Non-FictionMedicineSurgeryGastrointestinal & Colorectal Surgery
- Non-FictionMedicineSurgeryPlastic & Reconstructive Surgery
- Non-FictionMedicineClinical & Internal MedicineGastroenterology

























